PEX6
Basic information
Region (hg38): 6:42963865-42979181
Links
Phenotypes
GenCC
Source:
- peroxisome biogenesis disorder 4A (Zellweger) (Definitive), mode of inheritance: AR
- peroxisome biogenesis disorder 4A (Zellweger) (Definitive), mode of inheritance: AR
- Zellweger spectrum disorders (Supportive), mode of inheritance: AR
- autosomal recessive cerebellar ataxia-blindness-deafness syndrome (Supportive), mode of inheritance: AR
- peroxisome biogenesis disorder 4B (Definitive), mode of inheritance: AR
- peroxisome biogenesis disorder 4A (Zellweger) (Strong), mode of inheritance: AR
- peroxisome biogenesis disorder (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Heimler syndrome 2 (Peroxisome biogenesis disorder 4C) | AR | Audiologic/Otolaryngologic | Heimler syndrome 2, representing a mild peroxisomal biogenesis disorder, includes sensorineural hearing loss among other features, and early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic; Biochemical; Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic; Renal | 8940266; 8670792; 10408779; 11355018; 16530715; 17041890; 19877282; 21937992; 22894767; 26387595 |
ClinVar
This is a list of variants' phenotypes submitted to
- Peroxisome biogenesis disorder (91 variants)
- Heimler syndrome 2 (18 variants)
- Peroxisome biogenesis disorder 4A (Zellweger) (7 variants)
- not provided (6 variants)
- Zellweger spectrum disorders (4 variants)
- Peroxisome biogenesis disorder 4B (3 variants)
- Peroxisome biogenesis disorder 4A (Zellweger);Peroxisome biogenesis disorder 4B (2 variants)
- PEX6-related disorder (1 variants)
- Heimler syndrome 2;Peroxisome biogenesis disorder 4A (Zellweger);Peroxisome biogenesis disorder 4B (1 variants)
- Peroxisome biogenesis disorder 4B;Peroxisome biogenesis disorder 4A (Zellweger) (1 variants)
- Heimler syndrome 2;Peroxisome biogenesis disorder 4B;Peroxisome biogenesis disorder 4A (Zellweger) (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PEX6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 515 | 529 | |||
missense | 12 | 467 | 29 | 518 | ||
nonsense | 26 | 27 | 54 | |||
start loss | 4 | |||||
frameshift | 57 | 74 | 135 | |||
inframe indel | 14 | 17 | ||||
splice donor/acceptor (+/-2bp) | 35 | 42 | ||||
splice region | 24 | 67 | 1 | 92 | ||
non coding | 206 | 22 | 235 | |||
Total | 101 | 151 | 503 | 752 | 27 |
Highest pathogenic variant AF is 0.0000396
Variants in PEX6
This is a list of pathogenic ClinVar variants found in the PEX6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-42963889-GTTTA-G | Peroxisome biogenesis disorder 1A (Zellweger) • Peroxisome biogenesis disorder • PEX6 POLYMORPHISM • not specified | Conflicting classifications of pathogenicity (Jan 13, 2023) | ||
6-42963928-A-C | Peroxisome biogenesis disorder 4A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
6-42963967-C-T | Peroxisome biogenesis disorder 4A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
6-42963992-C-G | Peroxisome biogenesis disorder 4A (Zellweger) | Uncertain significance (Jan 13, 2018) | ||
6-42964016-G-A | Peroxisome biogenesis disorder 4A (Zellweger) | Benign (Oct 17, 2018) | ||
6-42964123-G-A | Peroxisome biogenesis disorder 4A (Zellweger) | Likely benign (Mar 10, 2019) | ||
6-42964153-A-AT | Likely benign (Sep 20, 2020) | |||
6-42964167-G-A | Peroxisome biogenesis disorder 4A (Zellweger) | Uncertain significance (Jan 12, 2018) | ||
6-42964335-C-T | Peroxisome biogenesis disorder | Likely benign (May 08, 2022) | ||
6-42964340-A-C | Peroxisome biogenesis disorder | Uncertain significance (Oct 17, 2022) | ||
6-42964340-A-T | Peroxisome biogenesis disorder | Uncertain significance (Aug 31, 2021) | ||
6-42964342-G-A | not specified • Peroxisome biogenesis disorder 4A (Zellweger) • Peroxisome biogenesis disorder • Zellweger spectrum disorders | Benign/Likely benign (Jan 31, 2024) | ||
6-42964350-C-T | Peroxisome biogenesis disorder | Likely benign (Jan 27, 2024) | ||
6-42964354-C-A | Peroxisome biogenesis disorder • Zellweger spectrum disorders • PEX6-related disorder | Uncertain significance (Dec 11, 2023) | ||
6-42964354-C-T | PEX6-related disorder | Uncertain significance (May 28, 2024) | ||
6-42964355-G-A | Peroxisome biogenesis disorder | Uncertain significance (Feb 15, 2023) | ||
6-42964357-T-G | Peroxisome biogenesis disorder | Uncertain significance (Sep 17, 2021) | ||
6-42964363-C-A | Peroxisome biogenesis disorder | Uncertain significance (Mar 26, 2020) | ||
6-42964363-C-T | Peroxisome biogenesis disorder | Uncertain significance (Nov 28, 2021) | ||
6-42964364-G-A | Peroxisome biogenesis disorder | Uncertain significance (Jun 27, 2022) | ||
6-42964365-C-G | Peroxisome biogenesis disorder | Uncertain significance (Aug 01, 2022) | ||
6-42964368-G-A | Peroxisome biogenesis disorder | Likely benign (Dec 01, 2023) | ||
6-42964370-A-G | Peroxisome biogenesis disorder • Inborn genetic diseases | Uncertain significance (Apr 25, 2023) | ||
6-42964371-C-G | Peroxisome biogenesis disorder 4A (Zellweger) • Peroxisome biogenesis disorder • Zellweger spectrum disorders | Conflicting classifications of pathogenicity (Feb 01, 2024) | ||
6-42964371-C-T | Peroxisome biogenesis disorder | Likely benign (Oct 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PEX6 | protein_coding | protein_coding | ENST00000304611 | 17 | 15351 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000625 | 1.00 | 125617 | 0 | 131 | 125748 | 0.000521 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.44 | 436 | 529 | 0.824 | 0.0000311 | 6093 |
Missense in Polyphen | 139 | 183.72 | 0.75659 | 2149 | ||
Synonymous | 0.362 | 220 | 227 | 0.969 | 0.0000120 | 2268 |
Loss of Function | 3.21 | 15 | 35.7 | 0.421 | 0.00000167 | 443 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000478 | 0.000478 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.000451 | 0.000323 |
European (Non-Finnish) | 0.000637 | 0.000633 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.00105 | 0.00105 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in peroxisome biosynthesis. Required for stability of the PTS1 receptor. Anchored by PEX26 to peroxisome membranes, possibly to form heteromeric AAA ATPase complexes required for the import of proteins into peroxisomes.;
- Disease
- DISEASE: Peroxisome biogenesis disorder 4A (PBD4A) [MIM:614862]: A fatal peroxisome biogenesis disorder belonging to the Zellweger disease spectrum and clinically characterized by severe neurologic dysfunction with profound psychomotor retardation, severe hypotonia and neonatal seizures, craniofacial abnormalities, liver dysfunction, and biochemically by the absence of peroxisomes. Additional features include cardiovascular and skeletal defects, renal cysts, ocular abnormalities, and hearing impairment. Most severely affected individuals with the classic form of the disease (classic Zellweger syndrome) die within the first year of life. {ECO:0000269|PubMed:10408779, ECO:0000269|PubMed:8670792}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peroxisome biogenesis disorder 4B (PBD4B) [MIM:614863]: A peroxisome biogenesis disorder that includes neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), two milder manifestations of the Zellweger disease spectrum. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy and vision impairment. Children with the NALD presentation may reach their teens, while patients with the IRD presentation may reach adulthood. The clinical conditions are often slowly progressive in particular with respect to loss of hearing and vision. The biochemical abnormalities include accumulation of phytanic acid, very long chain fatty acids (VLCFA), di- and trihydroxycholestanoic acid and pipecolic acid. {ECO:0000269|PubMed:11355018}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Heimler syndrome 2 (HMLR2) [MIM:616617]: A form of Heimler syndrome, a very mild peroxisome biogenesis disorder characterized by sensorineural hearing loss, amelogenesis imperfecta resulting in enamel hyoplasia of the secondary dentition, nail defects, and occasional or late-onset retinal pigmentation abnormalities. {ECO:0000269|PubMed:19105186, ECO:0000269|PubMed:26387595, ECO:0000269|PubMed:27302843}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Peroxisome - Homo sapiens (human);Metabolism of proteins;Peroxisomal protein import
(Consensus)
Recessive Scores
- pRec
- 0.206
Intolerance Scores
- loftool
- 0.114
- rvis_EVS
- 1.14
- rvis_percentile_EVS
- 92.34
Haploinsufficiency Scores
- pHI
- 0.366
- hipred
- N
- hipred_score
- 0.477
- ghis
- 0.422
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.452
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pex6
- Phenotype
Gene ontology
- Biological process
- protein targeting to peroxisome;peroxisome organization;protein import into peroxisome matrix;protein import into peroxisome matrix, translocation;protein stabilization
- Cellular component
- photoreceptor outer segment;cytoplasm;peroxisome;peroxisomal membrane;cytosol;photoreceptor cell cilium
- Molecular function
- protein binding;ATP binding;protein C-terminus binding;ATPase activity;ATPase activity, coupled;protein-containing complex binding